Model-based standardization using an outcome model with random effects.


Journal

Statistics in medicine
ISSN: 1097-0258
Titre abrégé: Stat Med
Pays: England
ID NLM: 8215016

Informations de publication

Date de publication:
15 08 2019
Historique:
received: 22 03 2018
revised: 03 04 2019
accepted: 03 04 2019
pubmed: 1 6 2019
medline: 21 10 2020
entrez: 1 6 2019
Statut: ppublish

Résumé

Model-based standardization uses a statistical outcome model or exposure model to estimate a population-average association that is unconfounded by selected covariates. With it, one can compare groups using a distribution of confounders identical in each group to that of a standard population. We develop an approach based on an outcome model, in which the mean of the outcome is modeled conditional on the exposure and the confounders. In our approach, there is a confounder that clusters the observations into a very large number of categories. We treat the parameters for the clusters as random effects. We use a between-within model to account for the association of the random effects not only with the exposure but also with the cluster population sizes. We review alternative approaches presented in the literature, and we compare the outcome-modeling approach to recently proposed exposure-modeling approaches incorporating random effects. To illustrate, we use 2014 to compare proportions of acute respiratory tract infection diagnoses with an antibiotic prescription for emergency department versus outpatient visits, adjusting for confounding by unmeasured patient level variables and measured diagnosis-level variables. We also present results of a simulation study.

Identifiants

pubmed: 31150151
doi: 10.1002/sim.8182
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3378-3394

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Auteurs

Zhongkai Wang (Z)

Department of Biostatistics, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, Florida.

Babette A Brumback (BA)

Department of Biostatistics, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, Florida.

Adel A Alrwisan (AA)

Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida.

Almut G Winterstein (AG)

Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH